nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—BCHE—peripheral nervous system neoplasm	0.734	1	CbGaD
Drospirenone—BCHE—Cisplatin—peripheral nervous system neoplasm	0.0696	0.396	CbGbCtD
Drospirenone—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0536	0.305	CbGbCtD
Drospirenone—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0526	0.299	CbGbCtD
Drospirenone—Cerebral infarction—Vincristine—peripheral nervous system neoplasm	0.0036	0.0403	CcSEcCtD
Drospirenone—Embolism—Tretinoin—peripheral nervous system neoplasm	0.0025	0.028	CcSEcCtD
Drospirenone—Embolism—Isotretinoin—peripheral nervous system neoplasm	0.0025	0.028	CcSEcCtD
Drospirenone—Thrombosis—Tretinoin—peripheral nervous system neoplasm	0.00227	0.0254	CcSEcCtD
Drospirenone—Thrombosis—Isotretinoin—peripheral nervous system neoplasm	0.00227	0.0254	CcSEcCtD
Drospirenone—Embolism—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.0212	CcSEcCtD
Drospirenone—Venous thromboembolism—Epirubicin—peripheral nervous system neoplasm	0.00181	0.0203	CcSEcCtD
Drospirenone—Thrombosis—Alitretinoin—peripheral nervous system neoplasm	0.00172	0.0193	CcSEcCtD
Drospirenone—Venous thromboembolism—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.0188	CcSEcCtD
Drospirenone—Cerebrovascular accident—Tretinoin—peripheral nervous system neoplasm	0.00119	0.0133	CcSEcCtD
Drospirenone—Cerebrovascular accident—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.0133	CcSEcCtD
Drospirenone—Affect lability—Tretinoin—peripheral nervous system neoplasm	0.00115	0.0129	CcSEcCtD
Drospirenone—Affect lability—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.0129	CcSEcCtD
Drospirenone—Mood swings—Isotretinoin—peripheral nervous system neoplasm	0.0011	0.0124	CcSEcCtD
Drospirenone—Mood swings—Tretinoin—peripheral nervous system neoplasm	0.0011	0.0124	CcSEcCtD
Drospirenone—Embolism venous—Epirubicin—peripheral nervous system neoplasm	0.00106	0.0118	CcSEcCtD
Drospirenone—Embolism venous—Doxorubicin—peripheral nervous system neoplasm	0.000977	0.0109	CcSEcCtD
Drospirenone—Cerebrovascular accident—Alitretinoin—peripheral nervous system neoplasm	0.000902	0.0101	CcSEcCtD
Drospirenone—Depression—Tretinoin—peripheral nervous system neoplasm	0.000896	0.01	CcSEcCtD
Drospirenone—Depression—Isotretinoin—peripheral nervous system neoplasm	0.000896	0.01	CcSEcCtD
Drospirenone—Acute coronary syndrome—Tretinoin—peripheral nervous system neoplasm	0.000886	0.00992	CcSEcCtD
Drospirenone—Acute coronary syndrome—Isotretinoin—peripheral nervous system neoplasm	0.000886	0.00992	CcSEcCtD
Drospirenone—Myocardial infarction—Tretinoin—peripheral nervous system neoplasm	0.000881	0.00986	CcSEcCtD
Drospirenone—Myocardial infarction—Isotretinoin—peripheral nervous system neoplasm	0.000881	0.00986	CcSEcCtD
Drospirenone—Affect lability—Alitretinoin—peripheral nervous system neoplasm	0.00087	0.00974	CcSEcCtD
Drospirenone—Mood swings—Alitretinoin—peripheral nervous system neoplasm	0.000837	0.00937	CcSEcCtD
Drospirenone—Embolism—Epirubicin—peripheral nervous system neoplasm	0.00083	0.00929	CcSEcCtD
Drospirenone—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.000818	0.00915	CcSEcCtD
Drospirenone—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.000813	0.0091	CcSEcCtD
Drospirenone—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.000811	0.00908	CcSEcCtD
Drospirenone—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.000811	0.00908	CcSEcCtD
Drospirenone—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.000807	0.00903	CcSEcCtD
Drospirenone—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.000807	0.00903	CcSEcCtD
Drospirenone—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.000801	0.00896	CcSEcCtD
Drospirenone—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.000796	0.00891	CcSEcCtD
Drospirenone—Cerebrovascular accident—Cisplatin—peripheral nervous system neoplasm	0.000769	0.0086	CcSEcCtD
Drospirenone—Embolism—Doxorubicin—peripheral nervous system neoplasm	0.000768	0.0086	CcSEcCtD
Drospirenone—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.000763	0.00854	CcSEcCtD
Drospirenone—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.000763	0.00854	CcSEcCtD
Drospirenone—Thrombosis—Epirubicin—peripheral nervous system neoplasm	0.000753	0.00843	CcSEcCtD
Drospirenone—Angiopathy—Topotecan—peripheral nervous system neoplasm	0.000738	0.00826	CcSEcCtD
Drospirenone—Angiopathy—Tretinoin—peripheral nervous system neoplasm	0.000732	0.00819	CcSEcCtD
Drospirenone—Angiopathy—Isotretinoin—peripheral nervous system neoplasm	0.000732	0.00819	CcSEcCtD
Drospirenone—Mental disorder—Tretinoin—peripheral nervous system neoplasm	0.000707	0.00791	CcSEcCtD
Drospirenone—Mental disorder—Isotretinoin—peripheral nervous system neoplasm	0.000707	0.00791	CcSEcCtD
Drospirenone—Thrombosis—Doxorubicin—peripheral nervous system neoplasm	0.000697	0.0078	CcSEcCtD
Drospirenone—Breast disorder—Cisplatin—peripheral nervous system neoplasm	0.000681	0.00762	CcSEcCtD
Drospirenone—Depression—Alitretinoin—peripheral nervous system neoplasm	0.000679	0.0076	CcSEcCtD
Drospirenone—Acute coronary syndrome—Alitretinoin—peripheral nervous system neoplasm	0.000672	0.00752	CcSEcCtD
Drospirenone—Myocardial infarction—Alitretinoin—peripheral nervous system neoplasm	0.000668	0.00747	CcSEcCtD
Drospirenone—Depression—Vincristine—peripheral nervous system neoplasm	0.000655	0.00733	CcSEcCtD
Drospirenone—Acute coronary syndrome—Vincristine—peripheral nervous system neoplasm	0.000647	0.00724	CcSEcCtD
Drospirenone—Myocardial infarction—Vincristine—peripheral nervous system neoplasm	0.000643	0.0072	CcSEcCtD
Drospirenone—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.000624	0.00698	CcSEcCtD
Drospirenone—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.000615	0.00688	CcSEcCtD
Drospirenone—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.000612	0.00684	CcSEcCtD
Drospirenone—Breast pain—Epirubicin—peripheral nervous system neoplasm	0.000611	0.00684	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000599	0.0067	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000594	0.00665	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000594	0.00665	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000586	0.00656	CcSEcCtD
Drospirenone—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.00647	CcSEcCtD
Drospirenone—Acute coronary syndrome—Cisplatin—peripheral nervous system neoplasm	0.000572	0.0064	CcSEcCtD
Drospirenone—Myocardial infarction—Cisplatin—peripheral nervous system neoplasm	0.000569	0.00637	CcSEcCtD
Drospirenone—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000567	0.00634	CcSEcCtD
Drospirenone—Breast pain—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.00632	CcSEcCtD
Drospirenone—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000562	0.00629	CcSEcCtD
Drospirenone—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000562	0.00629	CcSEcCtD
Drospirenone—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000561	0.00628	CcSEcCtD
Drospirenone—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000557	0.00623	CcSEcCtD
Drospirenone—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000557	0.00623	CcSEcCtD
Drospirenone—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.00621	CcSEcCtD
Drospirenone—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00055	0.00615	CcSEcCtD
Drospirenone—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000536	0.006	CcSEcCtD
Drospirenone—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.000535	0.00598	CcSEcCtD
Drospirenone—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.000524	0.00587	CcSEcCtD
Drospirenone—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.000521	0.00583	CcSEcCtD
Drospirenone—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000516	0.00578	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000499	0.00558	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000495	0.00554	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000495	0.00554	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000489	0.00547	CcSEcCtD
Drospirenone—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000451	0.00505	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00504	CcSEcCtD
Drospirenone—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000433	0.00485	CcSEcCtD
Drospirenone—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000426	0.00477	CcSEcCtD
Drospirenone—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000422	0.00472	CcSEcCtD
Drospirenone—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000411	0.0046	CcSEcCtD
Drospirenone—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000395	0.00442	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000384	0.00429	CcSEcCtD
Drospirenone—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000381	0.00426	CcSEcCtD
Drospirenone—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000381	0.00426	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000375	0.0042	CcSEcCtD
Drospirenone—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000366	0.0041	CcSEcCtD
Drospirenone—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.00409	CcSEcCtD
Drospirenone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000363	0.00406	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000361	0.00405	CcSEcCtD
Drospirenone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00036	0.00402	CcSEcCtD
Drospirenone—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.00394	CcSEcCtD
Drospirenone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.00394	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000351	0.00393	CcSEcCtD
Drospirenone—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00391	CcSEcCtD
Drospirenone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000343	0.00384	CcSEcCtD
Drospirenone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00381	CcSEcCtD
Drospirenone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00381	CcSEcCtD
Drospirenone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.00379	CcSEcCtD
Drospirenone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000336	0.00376	CcSEcCtD
Drospirenone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000329	0.00369	CcSEcCtD
Drospirenone—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.00362	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00032	0.00358	CcSEcCtD
Drospirenone—Megestrol acetate—ABCB1—peripheral nervous system neoplasm	0.000317	0.306	CrCbGaD
Drospirenone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000293	0.00328	CcSEcCtD
Drospirenone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000278	0.00312	CcSEcCtD
Drospirenone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00301	CcSEcCtD
Drospirenone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00299	CcSEcCtD
Drospirenone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.00289	CcSEcCtD
Drospirenone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00283	CcSEcCtD
Drospirenone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00279	CcSEcCtD
Drospirenone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000249	0.00278	CcSEcCtD
Drospirenone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.00277	CcSEcCtD
Drospirenone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000243	0.00272	CcSEcCtD
Drospirenone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00262	CcSEcCtD
Drospirenone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00262	CcSEcCtD
Drospirenone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00251	CcSEcCtD
Drospirenone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00022	0.00246	CcSEcCtD
Drospirenone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.00243	CcSEcCtD
Drospirenone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000201	0.00225	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000197	0.0022	CcSEcCtD
Drospirenone—Spironolactone—ABCB1—peripheral nervous system neoplasm	0.000197	0.19	CrCbGaD
Drospirenone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00209	CcSEcCtD
Drospirenone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000185	0.00207	CcSEcCtD
Drospirenone—Norethindrone—ABCB1—peripheral nervous system neoplasm	0.000183	0.177	CrCbGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00204	CcSEcCtD
Drospirenone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00193	CcSEcCtD
Drospirenone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.00191	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00184	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.0017	CcSEcCtD
Drospirenone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000131	0.126	CrCbGaD
Drospirenone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00126	CcSEcCtD
Drospirenone—Progesterone—ABCB1—peripheral nervous system neoplasm	0.000107	0.103	CrCbGaD
Drospirenone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00117	CcSEcCtD
Drospirenone—Testosterone—ABCB1—peripheral nervous system neoplasm	0.000101	0.0974	CrCbGaD
